EFFICACY AND SAFETY OF INTRAVENOUS USTEKINUMAB RE-INDUCTION THERAPY IN CROHN'S DISEASE PATIENTS WITH SECONDARY LOSS OF RESPONSE TO USTEKINUMAB MAINTENANCE THERAPY: WEEK 16 RESULTS FROM THE POWER TRIAL

被引：0
|
作者：
Lee, Scott D.
Schreiber, Stefan
Janneke, Christien
Van der Woude
Marin-Jimenez, Ignacio
Wolf, Douglas C.
Schnoy, Elisabeth
Salzberg, Bruce
Busse, Christopher
Nazar, Maciej
Langholff, Wayne
Borghorst, Stephan
Gasink, Christopher
Baker, Thomas
Godwin, Bridget
Feagan, Brian G.
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1027
引用
收藏
页码：S220 / S220
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of intravenous ustekinumab re-induction therapy in Crohn's disease patients with secondary loss of response to ustekinumab maintenance therapy: Week 16 results from the POWER trial
    Schreiber, S. W.
    Lee, S.
    Van der Woude, C. J.
    Marin-Jimenez, I.
    Wolf, D.
    Schnoy, E.
    Salzberg, B.
    Busse, C.
    Nazar, M.
    Langholff, W.
    Borghorst, S.
    Gasink, C.
    Baker, T.
    Godwin, B.
    Feagan, B.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 564 - 564
  • [2] Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy
    Bermejo, Fernando
    Jimenez, Laura
    Algaba, Alicia
    Vela, Milagros
    Bastida, Guillermo
    Merino, Olga
    Lopez-Garcia, Alicia
    Melcarne, Luigi
    Rodriguez-Lago, Iago
    de la Maza, Saioa
    Bouhmidi, Abdel
    Barreiro-de Acosta, Manuel
    Lopez-Serrano, Pilar
    Carrillo-Palau, Marta
    Mesonero, Francisco
    Orts, Beatriz
    Bonillo, Daniel
    Granja, Alicia
    Guerra, Ivan
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (01) : 41 - 47
  • [3] EFFICACY OF INTRAVENOUS USTEKINUMAB RE-INDUCTION IN PATIENTS WITH CROHN'S DISEASE WITH A LOSS OF RESPONSE
    Heron, Valerie
    Panaccione, Nicola
    Candido, Kristina
    Bessissow, Talat
    Bitton, Alain
    Seow, Cynthia H.
    Panaccione, Remo
    Afif, Waqqas
    GASTROENTEROLOGY, 2019, 156 (06) : S877 - S877
  • [4] Efficacy of intravenous ustekinumab re-induction in patients with Crohn's disease with a loss of response
    Heron, V.
    Panaccione, N.
    Candido, K.
    Bessissow, T.
    Bitton, A.
    Seow, C.
    Panaccione, R.
    Afif, W.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S347 - S348
  • [5] Pharmacokinetics, Exposure-Response Relationships, and Immunogenicity in Crohn's Disease Patients With Ustekinumab Secondary Loss of Response Following Ustekinumab IV Re-Induction: Week 16 Results From the POWER Study
    Feagan, Brian G.
    Lee, Scott D.
    van der Woude, C. Janneke
    Marin-Jimenez, Ignacio
    Wolf, Douglas C.
    Schnoy, Elisabeth
    Salzberg, Bruce
    Busse, Christopher
    Nazar, Maciej
    Langholff, Wayne
    Gasink, Christopher
    Baker, Thomas
    Godwin, Bridget
    Adedokun, Omoniyi
    Schreiber, Stefan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S622 - S622
  • [6] Efficacy and safety of intravenous ustekinumab maintenance therapy in Crohn's disease
    Perez, Benito Hermida
    Mata, Alejo Mancebo
    Turrion, Miguel Angel de Jorge
    Trastoy, Pilar Varela
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2023, 115 (06) : 340 - +
  • [7] Re-induction with intravenous Ustekinumab after secondary loss of response is a valid optimization strategy in Crohn's disease
    Huinink, Sebastiaan ten Bokkel
    Biemans, Vince
    Duijvestein, Marjolijn
    Pierik, Marieke
    Hoentjen, Frank
    West, Rachel L.
    van der Woude, Christien J.
    de Vries, Annemarie C.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E783 - E788
  • [8] Re-induction with intravenous Ustekinumab after secondary loss of response is a valid optimization strategy in Crohn's disease
    Huinink, Sebastiaan ten Bokkel
    Biemans, Vince
    Duijvestein, Marjolijn
    Pierik, Marieke
    Hoentjen, Frank
    West, Rachel L.
    van der Woude, Christien J.
    de Vries, Annemarie C.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E783 - E788
  • [9] Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
    Feagan, B. G.
    Sandborn, W. J.
    Gasink, C.
    Jacobstein, D.
    Lang, Y.
    Friedman, J. R.
    Blank, M. A.
    Johanns, J.
    Gao, L. -L.
    Miao, Y.
    Adedokun, O. J.
    Sands, B. E.
    Hanauer, S. B.
    Vermeire, S.
    Targan, S.
    Ghosh, S.
    de Villiers, W. J.
    Colombel, J. -F.
    Tulassay, Z.
    Seidler, U.
    Salzberg, B. A.
    Desreumaux, P.
    Lee, S. D.
    Loftus, E. V., Jr.
    Dieleman, L. A.
    Katz, S.
    Rutgeerts, P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (20): : 1946 - 1960
  • [10] Crohn's Disease: Induction and Maintenance Therapy with Ustekinumab
    Lorenz, Judith
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (01): : 14 - +
12345